Get the Stockscreener App
144.46
1.42%
-2.08
Repligen Corp stock is traded at $144.46, with a volume of 1.13M.
It is down -1.42% in the last 24 hours and up +4.00% over the past month.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
See More
Previous Close:
$146.54
Open:
$145.7
24h Volume:
1.13M
Relative Volume:
1.91
Market Cap:
$8.09B
Revenue:
$633.51M
Net Income/Loss:
$-8.10M
P/E Ratio:
71.16
EPS:
2.03
Net Cash Flow:
$131.26M
1W Performance:
-7.64%
1M Performance:
+4.00%
6M Performance:
+20.38%
1Y Performance:
-19.66%
1-Day Range:
$143.96
$150.56
1-Week Range:
$143.91
$161.24
52-Week Range:
$113.50
$211.13
Repligen Corp Stock (RGEN) Company Profile
Name
Repligen Corp
Sector
Industry
Phone
(781) 449-9560
Address
41 SEYON STREET, WALTHAM, MA
Compare RGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
144.46 | 8.09B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
524.43 | 186.79B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
227.68 | 65.83B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.76 | 41.92B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.27 | 34.83B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
331.40 | 24.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Canaccord Genuity | Hold |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-18-24 | Initiated | Guggenheim | Neutral |
| Dec-04-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Mar-28-23 | Initiated | The Benchmark Company | Buy |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-22 | Initiated | UBS | Buy |
| Oct-14-21 | Initiated | Exane BNP Paribas | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| May-07-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-23-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Nov-01-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-15-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-19 | Reiterated | First Analysis Sec | Outperform |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jul-22-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-17-18 | Upgrade | CL King | Neutral → Buy |
| Nov-12-18 | Downgrade | CL King | Buy → Neutral |
| Sep-26-18 | Initiated | H.C. Wainwright | Neutral |
| Dec-08-17 | Initiated | Citigroup | Buy |
| Dec-05-17 | Initiated | JP Morgan | Overweight |
| Nov-13-17 | Initiated | CL King | Buy |
| Oct-02-17 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Jul-21-17 | Initiated | William Blair | Outperform |
| Feb-13-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Repligen Corp Stock (RGEN) Latest News
Repligen (NASDAQ:RGEN) Research Coverage Started at Canaccord Genuity Group - Defense World
Repligen Corporation (RGEN) Fell Along with Peers - Yahoo Finance
StockNews.com Downgrades Repligen (NASDAQ:RGEN) to Sell - MarketBeat
Repligen Co. (NASDAQ:RGEN) Stock Holdings Lowered by HighTower Advisors LLC - Defense World
Tidal Investments LLC Acquires 6,558 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Franklin Resources Inc. Raises Stock Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Co. (NASDAQ:RGEN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Repligen (NASDAQ:RGEN) Coverage Initiated by Analysts at Canaccord Genuity Group - MarketBeat
Repligen (NASDAQ:RGEN) Earns Hold Rating from Analysts at Canaccord Genuity Group - MarketBeat
Canaccord initiates Repligen with Hold, sets $165 price target - Investing.com
BioLife Solutions Taps Repligen's Tony Hunt for Board, Strengthening CGT Leadership - StockTitan
Analysts Offer Predictions for Repligen FY2025 Earnings - Defense World
William Blair Decreases Earnings Estimates for Repligen - MarketBeat
Repligen's SWOT analysis: bioprocessing firm's stock poised for growth - Investing.com
Y Intercept Hong Kong Ltd Takes Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
William Blair Issues Positive Outlook for Repligen Earnings - Defense World
William Blair Issues Positive Forecast for Repligen Earnings - MarketBeat
RGENRepligen Corp Latest Stock News & Market Updates - StockTitan
Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report - EIN News
State Street Corp Sells 113,741 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Janus Henderson Group PLC Has $3.53 Million Stake in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen's 2023 Sustainability Report Shows 68% Drop in Emissions, Major Clean Energy Push - StockTitan
RGEN Crosses Above Key Moving Average Level - Nasdaq
Several Factors Lifted Repligen Corporation (RGEN) in Q3 - Yahoo Finance
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns - The Manila Times
Repligen Unveils Breakthrough mRNA Purification Tech: Revolutionary 1-Minute RNA Processing Solution - StockTitan
Two Sigma Advisers LP Grows Stock Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Co. (NASDAQ:RGEN) Shares Bought by Worldquant Millennium Advisors LLC - MarketBeat
BNP Paribas Financial Markets Has $2.13 Million Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Co. (NASDAQ:RGEN) Shares Sold by Intech Investment Management LLC - MarketBeat
Intech Investment Management LLC Sells 7,662 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Point72 Asset Management L.P. Buys 9,387 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $31.05 Million Stake in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Fmr LLC Sells 641,519 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Miura Global Management LLC Has $744,000 Stake in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Cinctive Capital Management LP Invests $1.12 Million in Repligen Co. (NASDAQ:RGEN) - MarketBeat
12,500 Shares in Repligen Co. (NASDAQ:RGEN) Bought by Erste Asset Management GmbH - MarketBeat
Bamco Inc. NY Lowers Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Paloma Partners Management Co Purchases 5,047 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Co. (NASDAQ:RGEN) Shares Purchased by Bank of Montreal Can - MarketBeat
13,976 Shares in Repligen Co. (NASDAQ:RGEN) Purchased by Point72 Asia Singapore Pte. Ltd. - MarketBeat
Hollow Fiber Filtration Market Growth in Future Scope 2024-2031 - openPR
American Capital Management Inc. Grows Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Charles Schwab Investment Management Inc. Buys 5,478 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Braidwell LP Buys 73,272 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Citigroup Inc. Lowers Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Daiwa Securities Group Inc. Reduces Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen's SWOT analysis: bioprocessing leader faces growth challenges - Investing.com
Repligen Corp (RGEN) Shares Up 3.12% on Nov 25 - GuruFocus.com
Pathstone Holdings LLC Has $3.32 Million Stake in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Corp Stock (RGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):